USA Rare Earth
USAR
6.27
-0.60
-8.73%
USA Rare Earth
US · USAR
#2115 by market cap
Listed 2023
6.27
-0.60
-8.73%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:59
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.57, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 4 years
Margins
- Gross margin
- 11.87%
- Operating margin
- -3,621.61%
- Net margin
- -19,751.25%
Key ratios & quality
- Altman Z-Scorei
- 6.57
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1.64M |
| Gross profit | -210.00K | -308.00K | 0 | 195.00K |
| Selling & admin expenses | 19.78M | 21.09M | 9.24M | 43.14M |
| Research & development | 271.00K | 1.64M | 6.34M | 15.89M |
| Operating profit | -24.26M | -24.79M | -15.59M | -59.50M |
| Pretax profit | -25.54M | -8.54M | -16.39M | -298.68M |
| Tax | -- | -- | 0 | -160.00K |
| Net profit | -25.54M | -8.54M | -16.39M | -298.52M |
| Basic EPS | 0 | 0 | 0 | -3 |
| Diluted EPS | -0.40 | -0.12 | -0.29 | -3.31 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 0 | -- | -- | 5.70M | 5.82M | 3.00M |
| Gross profit | 0 | -- | -- | 106.00K | -1.58M | -19.88M |
| Selling & admin expenses | 6.23M | 11.41M | 18.47M | 21.18M | 32.61M | 103.66M |
| Research & development | 2.58M | 4.45M | 7.17M | 14.25M | 10.77M | 16.52M |
| Operating profit | -8.80M | -15.86M | -26.12M | -36.47M | -46.07M | -141.44M |
| Pretax profit | -142.71M | -156.99M | -50.66M | -68.65M | -12.48M | 6.61M |
| Tax | 0 | -- | -- | -577.00K | -513.00K | -5.10M |
| Net profit | -142.71M | -156.99M | -50.50M | -68.07M | -11.96M | 11.71M |
| Basic EPS | -2 | -2 | 0 | 0 | 0 | 0 |
| Diluted EPS | -1.54 | -1.64 | -0.40 | -0.34 | -0.05 | -0.02 |
Balance sheet
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total current assets | 27.32M | 499.66K | 22.27M | 385.38M |
| Cash & ST investments | 26.97M | 275.67K | 16.76M | 359.93M |
| Inventory | -- | -- | 0 | 18.54M |
| Total assets | 66.86M | 259.47M | 69.07M | 695.00M |
| Total current liabilities | 10.74M | 309.99K | 6.93M | 37.91M |
| Short-term debt | 442.00K | -- | 854.00K | 2.27M |
| Long-term debt | -- | -- | -- | -- |
| Total liabilities | 34,810,000.00 | 13,409,985.00 | 36,298,000.00 | 200,713,000.00 |
| Total equity | 32.05M | 246.06M | 32.77M | 494.29M |
| Retained earnings | -- | -- | -72.87M | -387.36M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 123.55M | 258.88M | 385.38M | 1.79B | 1.67B | 1.22B |
| Cash & ST investments | 121.79M | 257.61M | 359.93M | 1.75B | 1.53B | 1.09B |
| Inventory | -- | -- | 18.54M | 28.43M | 50.14M | 88.84M |
| Total assets | 179.70M | 323.33M | 695.00M | 2.13B | 3.00B | 6.95B |
| Total current liabilities | 8.18M | 15.68M | 37.91M | 49.34M | 51.01M | 183.95M |
| Short-term debt | 421.00K | 426.00K | 2.27M | 518.00K | 640.00K | 869.00K |
| Long-term debt | -- | -- | -- | -- | -- | 305.56M |
| Total liabilities | 311,635,000.00 | 381,907,000.00 | 200,713,000.00 | 255,880,000.00 | 461,855,000.00 | 2,137,466,000.00 |
| Total equity | -131.93M | -58.58M | 494.29M | 1.88B | 2.54B | 4.82B |
| Retained earnings | -180.50M | -337.18M | -387.36M | -454.35M | -464.68M | -- |
Cash flow
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | -14.80M | -21.93M | -12.99M | -48.99M |
| Depreciation & amortization | 671.00K | 718.00K | 389.00K | 1.59M |
| Free cash flow | -19.91M | -27.88M | -16.10M | -86.34M |
| Dividends paid | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 13.11M | 0 | 190.08M |
| Ending cash balance | 26.97M | 13.20M | 16.76M | 359.93M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | -7.91M | -2.85M | -27.90M | -18.46M | -56.87M | -143.69M |
| Depreciation & amortization | 272.00K | 147.00K | 1.10M | 2.10M | 2.48M | -- |
| Free cash flow | -11.16M | -9.95M | -51.86M | -57.10M | -126.62M | -226.22M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 75.00M | 115.08M | 0 | 1.50B | 0 | 0 |
| Ending cash balance | 121.79M | 257.61M | 359.93M | 1.75B | 1.59B | 1.16B |
Returns & efficiency
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| ROE %i | -86.78 | -22.26 | 40.35 | -131.75 |
| ROA %i | -35.67 | -11.94 | 19.38 | -90.25 |
| ROIC %i | -84.02 | -21.61 | 38.69 | -132.55 |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -18,170.72 |
| FCF / sales %i | -- | -- | -- | -- |
| Current ratioi | 2.54 | 1.61 | 3.22 | 10.17 |
| Quick ratioi | 2.51 | 0.89 | 2.42 | 9.59 |
| Debt / assetsi | 1.35 | -- | 1.24 | 0.44 |
| LT debt / equityi | 1.67 | -- | -- | 0.16 |
| Interest coveragei | -- | -- | -- | -2,147.81 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -131.75 | -48.32 | -25.89 | -5.04 |
| ROA %i | -66.42 | -128.09 | -90.25 | -39.83 | -19.58 | -3.29 |
| ROIC %i | -- | -- | -132.55 | -50.06 | -25.89 | -4.73 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -18,170.72 | -5,699.03 | -2,160.54 | -1,701.73 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 15.11 | 16.51 | 10.17 | 36.29 | 32.79 | 6.62 |
| Quick ratioi | 14.90 | 16.43 | 9.59 | 35.60 | 30.12 | 5.96 |
| Debt / assetsi | 0.79 | 0.41 | 0.44 | 0.06 | 0.11 | 4.44 |
| LT debt / equityi | -- | -- | 0.16 | 0.04 | 0.10 | 6.40 |
| Interest coveragei | -- | -- | -2,147.81 | -648.63 | -64.57 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Vertically integrated, domestic rare earth element magnet production supply chain100.00%
Quote time 2026-11-20 19:59:58 · For reference only, not investment advice and not tailored to your situation.
USA Rare Earth discussion 0 comments